STAT

DECEMBER 11, 2023

WASHINGTON — The House passed a relatively major health care package late Monday, an end-of-year victory after the same policies had to be yanked from consideration in September because they lacked bipartisan support. Though the package is unlikely to pass the Senate and become law as-is, its advancing through the House does make each included policy more attractive for a potential government funding deal, as lawmakers draw closer to the Jan. 19 deadline to fund the government and extend

Packaging 145

Packaging Hospitals 145

Pharmacy Times

DECEMBER 11, 2023

More drugs plus a growing population of older and sicker patients is creating medication-alert overload for already stressed clinicians.

Hospitals 145

Hospitals 145

STAT

DECEMBER 11, 2023

Oliver McGowan was 18 years old when he was hospitalized in England with recurrent seizures and pneumonia. He was autistic, and he and his parents had one specific request for the medical team: no antipsychotic medications. When he had taken them in the past, they made his seizures worse and had devastating effects on his mood. Despite the family’s vehement protests, doctors gave him an antipsychotic.

Medical Schools 144

Medical Schools Communication Hospitals 144

Pharmacy Times

DECEMBER 11, 2023

The study results demonstrated that 92% of patients treated with benralizumab were able to safely reduce inhaled steroid dose, and more than 60% could stop use entirely.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

DECEMBER 11, 2023

During 2022, drugmakers substantially raised prices on eight widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $1.2 billion last year, according to a new report. The drug for which spending increased the most due to a price increase was Humira, which is used to treat rheumatoid arthritis, plaque psoriasis, and other disorders.

Insurance 143

Insurance 143

Pharmacy Times

DECEMBER 11, 2023

The model may help clinicians identify patients who would benefit from disease-specific therapies or enrollment into clinical trials.

139

139

Fierce Healthcare

DECEMBER 11, 2023

The Lower Costs, More Transparency Act, which advances policies to force pharmacy benefit managers and hospitals to meet price transparency standards, passed on the House floor Monday by a vote of | Members on both sides of the aisle are celebrating successful efforts to codify price transparency requirements and establish site-neutral payments in the Lower Costs, More Transparency Act passed by the House of Representatives on Monday.

Hospitals 138

Hospitals 138

STAT

DECEMBER 11, 2023

The approval Friday of Bluebird Bio’s gene therapy for sickle cell disease should have been a momentum-swinging achievement for the long-struggling biotech. Instead, the company mispriced its new drug and fumbled a pivotal financial lifeline. The consequences of these strategic blunders — arguably, self-inflicted — could imperil Bluebird’s independence, perhaps even its survival.

Labelling 142

Labelling 142

Pharmacy Times

DECEMBER 11, 2023

The pharmacist can help patients to manage symptoms throughout the entire treatment journey.

132

132

STAT

DECEMBER 11, 2023

One of the most prestigious names in medical publishing is going all in on artificial intelligence. The New England Journal of Medicine on Monday will launch NEJM AI , a monthly, online-only publication that will focus on evaluating applications of artificial intelligence in clinical medicine. The journal will also publish review articles, policy perspectives, and educational materials for physicians and computer scientists.

138

138

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

DECEMBER 11, 2023

The results found that 93% of individuals in the high-risk group presented persistently positive antiphospholipid antibodies, compared with 47% of individuals in the lower-risk group.

132

132

STAT

DECEMBER 11, 2023

Vertex Pharmaceuticals made history Friday when it received regulatory approval for a medicine that could alter people’s DNA. While the company celebrated, its founder, Joshua Boger, looked on like a proud parent. Boger, 72, founded Vertex in 1989 and served in various roles until 2017. To this day, he lives next door to the company’s headquarters in Boston’s Seaport District, in a high-rise penthouse where he can quite literally look in on the biotech’s offices.

Labelling 138

Labelling 138

Fierce Healthcare

DECEMBER 11, 2023

Navigating healthcare benefits can be a frustrating and confusing experience for most health plan members and employees. | Medefy Health developed a mobile-first healthcare benefits navigation platform that offers real-time guidance from actual people, not AI-based chatbots. The company has seen rapid growth and landed $10 million in series A funding to build out its tech platform.

130

130

STAT

DECEMBER 11, 2023

In its latest bid to police the pharmaceutical industry, the U.S. Federal Trade Commission sought to block Sanofi from licensing a Pompe disease treatment made by another drug company. And in response, Sanofi is ending the deal. Sanofi sought the rights to the medication from Maze Therapeutics, but the regulator argued the deal — valued at $775 million — would eliminate a “nascent competitor” that could, otherwise, challenge the monopoly Sanofi has in the market for P

134

134

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

DECEMBER 11, 2023

Floreo, maker of virtaul reality (VR) behavioral therapy content, has received the Food and Drug Administration’s breakthrough device designation. | Floreo says it seeks full market authorization to further recognize its effectiveness and to open up reimbursement pathways for its tech to reach more families.

Labelling 128

Labelling FDA 128

STAT

DECEMBER 11, 2023

Amid fears of superbugs, the sale of medically important antibiotics given to food-producing livestock rose by 4% overall in the U.S. in 2022, an increase that prompted advocates to complain that not enough is being done to thwart antibiotic resistance. In particular, the sale and distribution of tetracycline, which accounted for 65% of the medically important antibiotics given the livestock, increased by 4%, according to the latest annual report from the U.S.

133

133

pharmaphorum

DECEMBER 11, 2023

Predictive genetic testing offers the greatest promise and ethical challenge of our time Mike.

126

126

STAT

DECEMBER 11, 2023

AdvaMed named Peter Arduini, CEO of GE HealthCare, chair of its board of directors on Monday. The medical device lobby also announced the creation of a new division focused on policy issues for medical imaging technology. Arduini has been acting chair over the past few weeks, after former Johnson & Johnson MedTech CEO Ashley McEvoy stepped down.

125

125

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

DECEMBER 11, 2023

By combining the administration of psychedelic compounds with therapeutic support, ketamine-assisted therapy is proving remarkable efficacy in treating mental health conditions.

Compounding 123

Compounding 123

STAT

DECEMBER 11, 2023

Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks. The younger Glimcher took that advice to heart. In the late 1990s at her Harvard immunology lab, Glimcher and her postdoctoral student began a series of experiments that colleagues deemed “crazy.

Hospitals 122

Hospitals 122

Pharmacy Times

DECEMBER 11, 2023

Only 20% of the patient population were reported as being “very good” sleepers when it comes to sleep disturbances.

123

123

European Pharmaceutical Review

DECEMBER 11, 2023

Results from MaaT Pharma’s Early Access Program (EAP) for its microbiome-based therapy MaaT013, have demonstrated positive overall response and overall survival rates in European patients with graft-versus-host disease (GvHD). The findings were presented at the 2023 American Society of Hematology (ASH) Annual Meeting. MaaT013 is an off-the-shelf, pooled-donor, enema Microbiome Ecosystem Therapy TM.

Hospitals 119

Hospitals 119

Pharmacy Times

DECEMBER 11, 2023

Seven new agents have received FDA approval since October 2022.

FDA 122

FDA 122

pharmaphorum

DECEMBER 11, 2023

How buying Canadian insulin aids Americans without medical coverage Mike.

118

118

Fierce Pharma

DECEMBER 11, 2023

ASH: Abecma’s survival data show why FDA wanted expert meeting on the Bristol Myers cell therapy aliu Mon, 12/11/2023 - 14:51

FDA 116

FDA 116

STAT

DECEMBER 11, 2023

WASHINGTON — An executive at insurance giant UnitedHealth Group is slated to be the next leader of the health insurance industry’s largest lobbying group, the group announced Monday. AHIP has selected Mike Tuffin, who’s currently UnitedHealth’s senior vice president for external affairs and head of U.S. government affairs, to be its next leader, after Matt Eyles announced his retirement from the group earlier this year after a five-year tenure.

Insurance 115

Insurance 115

pharmaphorum

DECEMBER 11, 2023

MSD, Moderna take mRNA jab into phase 3 for lung cancer Phil.

115

115

Drug Topics

DECEMBER 11, 2023

Two posters presented at ASHP Midyear 2023 explored the impact of diabetes management interventions among patients with diabetes.

112

112

Fierce Healthcare

DECEMBER 11, 2023

More than half of global health insurers are expecting significant increases in healthcare costs over the next several years, according to a new report. | More than half of global health insurers are expecting significant increases in healthcare costs over the next several years, according to a new report.

Insurance 111

Insurance 111

Drug Topics

DECEMBER 11, 2023

Three posters presented at ASHP Midyear 2023 delved deeper into the topic of antimicrobial stewardship programs and their impact on antibiotic resistance.

112

112

Fierce Pharma

DECEMBER 11, 2023

After many years of tracking the pharmaceutical industry’s pricing tactics, the Institute for Clinical and Economic Review (ICER) is once again placing a spotlight on the price increases that end u | The Institute for Clinical and Economic Review (ICER)’s fifth annual report on unsupported price increases (UPI) puts Humira in the top spot of offenders.

111

111

pharmaphorum

DECEMBER 11, 2023

ASH: Pfizer builds case for long-acting haemophilia drug Phil.

111

111

STAT

DECEMBER 11, 2023

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the usual routine of online meetings and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or three of stimulation.

Labelling 110

Labelling 110